|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siewert JR and Ott K: Are squamous and
adenocarcinomas of the esophagus the same disease? Semin Radiat
Oncol. 17:38–44. 2007. View Article : Google Scholar
|
|
4
|
Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun
ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of
esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moorcraft SY and Chau I: Investigational
therapies targeting the ErbB family in oesophagogastric cancer.
Expert Opin Investig Drugs. 23:1349–1363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jankowsky E: RNA helicases at work:
Binding and rearranging. Trends Biochem Sci. 36:19–29. 2011.
View Article : Google Scholar :
|
|
7
|
Linder P and Fuller-Pace F: Happy
birthday: 25 years of DEAD-box proteins. Methods Mol Biol.
1259:17–33. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fuller-Pace FV: DEAD box RNA helicase
functions in cancer. RNA Biol. 10:121–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Heerma van Voss MR, Vesuna F, Trumpi K,
Brilliant J, Berlinicke C, de Leng W, Kranenburg O, Offerhaus GJ,
Bürger H, van der Wall E, et al: Identification of the DEAD box RNA
helicase DDX3 as a therapeutic target in colorectal cancer.
Oncotarget. 6:28312–28326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bol GM, Vesuna F, Xie M, Zeng J, Aziz K,
Gandhi N, Levine A, Irving A, Korz D, Tantravedi S, et al:
Targeting DDX3 with a small molecule inhibitor for lung cancer
therapy. EMBO Mol Med. 7:648–669. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu YZ and Query CC: Competition between
the ATPase Prp5 and branch region-U2 snRNA pairing modulates the
fidelity of spliceosome assembly. Mol Cell. 28:838–849. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kosowski TR, Keys HR, Quan TK and Ruby SW:
DExD/H-box Prp5 protein is in the spliceosome during most of the
splicing cycle. RNA. 15:1345–1362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hozumi S, Hirabayashi R, Yoshizawa A,
Ogata M, Ishitani T, Tsutsumi M, Kuroiwa A, Itoh M and Kikuchi Y:
DEAD-box protein Ddx46 is required for the development of the
digestive organs and brain in zebrafish. PLoS One. 7:e336752012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirabayashi R, Hozumi S, Higashijima S and
Kikuchi Y: Ddx46 is required for multi-lineage differentiation of
hematopoietic stem cells in zebrafish. Stem Cells Dev.
22:2532–2542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abdelhaleem M, Maltais L and Wain H: The
human DDX and DHX gene families of putative RNA helicases.
Genomics. 81:618–622. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Ma Y, Huang P, Du A, Yang X, Zhang
S, Xing C, Liu F and Cao J: Lentiviral DDX46 knockdown inhibits
growth and induces apoptosis in human colorectal cancer cells.
Gene. 560:237–244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Linder P, Lasko PF, Ashburner M, Leroy P,
Nielsen PJ, Nishi K, Schnier J and Slonimski PP: Birth of the
D-E-A-D box. Nature. 337:121–122. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Germain DR, Graham K, Glubrecht DD, Hugh
JC, Mackey JR and Godbout R: DEAD box 1: A novel and independent
prognostic marker for early recurrence in breast cancer. Breast
Cancer Res Treat. 127:53–63. 2011. View Article : Google Scholar
|
|
19
|
Lu D and Yunis JJ: Cloning, expression and
localization of an RNA helicase gene from a human lymphoid cell
line with chromosomal breakpoint 11q23.3. Nucleic Acids Res.
20:1967–1972. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akao Y, Marukawa O, Morikawa H, Nakao K,
Kamei M, Hachiya T and Tsujimoto Y: The rck/p54 candidate
proto-oncogene product is a 54-kilodalton D-E-A-D box protein
differentially expressed in human and mouse tissues. Cancer Res.
55:3444–3449. 1995.PubMed/NCBI
|
|
21
|
Hashimoto K, Nakagawa Y, Morikawa H, Niki
M, Egashira Y, Hirata I, Katsu K and Akao Y: Co-overexpression of
DEAD box protein rck/p54 and c-myc protein in human colorectal
adenomas and the relevance of their expression in cultured cell
lines. Carcinogenesis. 22:1965–1970. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakagawa Y, Morikawa H, Hirata I, Shiozaki
M, Matsumoto A, Maemura K, Nishikawa T, Niki M, Tanigawa N, Ikegami
M, et al: Overexpression of rck/p54, a DEAD box protein, in human
colorectal tumours. Br J Cancer. 80:914–917. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyaji K, Nakagawa Y, Matsumoto K, Yoshida
H, Morikawa H, Hongou Y, Arisaka Y, Kojima H, Inoue T, Hirata I, et
al: Overexpression of a DEAD box/RNA helicase protein, rck/p54, in
human hepatocytes from patients with hepatitis C virus-related
chronic hepatitis and its implication in hepatocellular
carcinogenesis. J Viral Hepat. 10:241–248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Causevic M, Hislop RG, Kernohan NM, Carey
FA, Kay RA, Steele RJ and Fuller-Pace FV: Overexpression and
polyubiquitylation of the DEAD-box RNA helicase p68 in colorectal
tumours. Oncogene. 20:7734–7743. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Lin C and Liu ZR: Phosphorylations
of DEAD box p68 RNA helicase are associated with cancer development
and cell proliferation. Mol Cancer Res. 3:355–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shin S, Rossow KL, Grande JP and Janknecht
R: Involvement of RNA helicases p68 and p72 in colon cancer. Cancer
Res. 67:7572–7578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clark EL, Coulson A, Dalgliesh C, Rajan P,
Nicol SM, Fleming S, Heer R, Gaughan L, Leung HY, Elliott DJ, et
al: The RNA helicase p68 is a novel androgen receptor coactivator
involved in splicing and is overexpressed in prostate cancer.
Cancer Res. 68:7938–7946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wortham NC, Ahamed E, Nicol SM, Thomas RS,
Periyasamy M, Jiang J, Ochocka AM, Shousha S, Huson L, Bray SE, et
al: The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent
transcription and cell growth, and is associated with improved
survival in ERalpha-positive breast cancer. Oncogene. 28:4053–4064.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mazurek A, Luo W, Krasnitz A, Hicks J,
Powers RS and Stillman B: DDX5 regulates DNA replication and is
required for cell proliferation in a subset of breast cancer cells.
Cancer Discov. 2:812–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang SJ, Zhang C, You Y and Shi CM:
Overexpression of RNA helicase p68 protein in cutaneous squamous
cell carcinoma. Clin Exp Dermatol. 37:882–888. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang R, Jiao Z, Li R, Yue H and Chen L:
p68 RNA helicase promotes glioma cell proliferation in vitro and in
vivo via direct regulation of NF-κB transcription factor p50.
Neuro-oncol. 14:1116–1124. 2012. View Article : Google Scholar
|
|
32
|
Sugiura T, Nagano Y and Noguchi Y: DDX39,
upregulated in lung squamous cell cancer, displays RNA helicase
activities and promotes cancer cell growth. Cancer Biol Ther.
6:957–964. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kikuta K, Kubota D, Saito T, Orita H,
Yoshida A, Tsuda H, Suehara Y, Katai H, Shimada Y, Toyama Y, et al:
Clinical proteomics identified ATP-dependent RNA helicase DDX39 as
a novel biomarker to predict poor prognosis of patients with
gastrointestinal stromal tumor. J Proteomics. 75:1089–1098. 2012.
View Article : Google Scholar
|
|
34
|
Lin F, Wang R, Shen JJ, Wang X, Gao P,
Dong K and Zhang HZ: Knockdown of RCK/p54 expression by RNAi
inhibits proliferation of human colorectal cancer cells in vitro
and in vivo. Cancer Biol Ther. 7:1669–1676. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nicol SM, Bray SE, Black HD, Lorimore SA,
Wright EG, Lane DP, Meek DW, Coates PJ and Fuller-Pace FV: The RNA
helicase p68 (DDX5) is selectively required for the induction of
p53-dependent p21 expression and cell-cycle arrest after DNA
damage. Oncogene. 32:3461–3469. 2013. View Article : Google Scholar
|
|
36
|
Testa JR and Bellacosa A: AKT plays a
central role in tumorigenesis. Proc Natl Acad Sci USA.
98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mandal M, Kim S, Younes MN, Jasser SA,
El-Naggar AK, Mills GB and Myers JN: The Akt inhibitor KP372–1
suppresses Akt activity and cell proliferation and induces
apoptosis in thyroid cancer cells. Br J Cancer. 92:1899–1905. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
